Global drug giant GlaxoSmithKline is building the largest rooftop solar project in the U.S. at its York facility, reports Bloomberg.
The three-megawatt solar system will use 11,000 solar panels made by Suntech Power Holdings Co. and provide all of the electricity the building consumes during the year, London-based Glaxo said today in a statement.
Glaxo is trying to meet a goal of reducing electricity use 45 percent by 2015, and plans to start a second three-megawatt system at its U.S. headquarters in Pittsburgh by the end of next year, said Larry Brown, vice president of North America Supply at Glaxo’s consumer health care unit.
For the York installation, Glaxo expects to receive a $1 million grant from the state of Pennsylvania and $4.1 million in a federal tax grant, as well as generate renewable energy credits to help offset the system costs. It should pay for itself through lower power bills in five years, and the electricity is free after that, Brown said. Original source: BloombergRead the full story here.